UA97696U - METHOD OF PREVENTING CHILD DEVELOPMENT IN CHILDREN - Google Patents
METHOD OF PREVENTING CHILD DEVELOPMENT IN CHILDRENInfo
- Publication number
- UA97696U UA97696U UAU201412505U UAU201412505U UA97696U UA 97696 U UA97696 U UA 97696U UA U201412505 U UAU201412505 U UA U201412505U UA U201412505 U UAU201412505 U UA U201412505U UA 97696 U UA97696 U UA 97696U
- Authority
- UA
- Ukraine
- Prior art keywords
- children
- drops
- day
- years
- treatment
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 230000008131 children development Effects 0.000 title 1
- 206010067125 Liver injury Diseases 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 231100000234 hepatic damage Toxicity 0.000 abstract 1
- 230000008818 liver damage Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Спосіб попередження розвитку уражень печінки у дітей включає застосування антибактеріальної терапії, причому додатково протягом всього курсу лікування призначають препарат "Галстена" в разовій дозі для дітей старше 12 років по 10 крапель або 1 таблетці, дітям віком 5-12 років - по 5-7 крапель або 1/2 таблетки, дітям 2-4 років - по 2-4 краплі і дітям молодше двох років - по 1 краплі, кратність прийому в перші два дні лікування для крапель - до 8 разів на добу, для таблеток - до 4 разів на добу, з 3-го дня лікування краплі призначають в разових дозах 3 рази на добу, таблетки - 2 рази на добу.A method of preventing the development of liver damage in children involves the use of antibacterial therapy, and additionally throughout the course of treatment prescribe the drug "Galsten" in a single dose for children over 12 years of 10 drops or 1 tablet, children aged 5-12 years - 5-7 drops or 1/2 tablet, children 2-4 years - 2-4 drops and children under two years - 1 drop, the frequency of taking the first two days of treatment for drops - up to 8 times a day, for tablets - up to 4 times day, from the 3rd day of treatment drops are prescribed in single doses 3 times a day y, tablets - 2 times a day.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201412505U UA97696U (en) | 2014-11-21 | 2014-11-21 | METHOD OF PREVENTING CHILD DEVELOPMENT IN CHILDREN |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201412505U UA97696U (en) | 2014-11-21 | 2014-11-21 | METHOD OF PREVENTING CHILD DEVELOPMENT IN CHILDREN |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA97696U true UA97696U (en) | 2015-03-25 |
Family
ID=53501269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201412505U UA97696U (en) | 2014-11-21 | 2014-11-21 | METHOD OF PREVENTING CHILD DEVELOPMENT IN CHILDREN |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA97696U (en) |
-
2014
- 2014-11-21 UA UAU201412505U patent/UA97696U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX378273B (en) | ACTIVE COMPOUNDS TOWARDS BROMODOMAINS. | |
| MX365939B (en) | Nuclear transport modulators and uses thereof. | |
| HUE049341T2 (en) | Substituted indazoles, process for their preparation, pharmaceutical preparations containing them and their use in the preparation of pharmaceutical preparations | |
| MX2020009780A (en) | Autotaxin inhibitor compounds. | |
| EP3311376C0 (en) | Devices and methods for drug administration and mixing, as well as training in the correct techniques therefor | |
| NZ746338A (en) | Use of alphavirus and zap inhibitor in the preparation of an antitumor drug, and antitumor drugs comprising the same | |
| PH12016500863A1 (en) | Tetracyclic autotaxin inhibitors | |
| EA201691918A1 (en) | PHARMACEUTICAL COMPOSITIONS OF KINAZ INHIBITOR KINAZ OF THE RAF FAMILY, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE | |
| WO2014121137A3 (en) | Compositions and methods for the treatment of neurodegenerative and other diseases | |
| MX2017003216A (en) | Use of il-17 antagonists to inhibit the progression of structural damage in psoriatic arthritis patients. | |
| DK3452100T3 (en) | PHARMACEUTICAL CARRIERS CONTAINING MIRNAUES FOR USE IN THE TREATMENT OF FIBROTIC DISEASES CAUSED BY HYPERGLYCHEMIA | |
| CY1119532T1 (en) | (S) -PYRILDOL AND THE PHARMACEUTALLY ACCEPTABLE SALTS FOR USE IN MEDICINE | |
| EP3137204C0 (en) | PHARMACY FORMULATION MANUFACTURING SYSTEM AND PHARMACY FORMULATION MANUFACTURING METHOD FOR PRODUCING INDIVIDUAL PHARMACEUTICAL FORMULATURES | |
| MX389474B (en) | DIMETHYL FUMARATE AND VACCINATION REGIMEN. | |
| MX364528B (en) | Withanolides useful for the treatment of neurodegenerative diseases. | |
| CY1119522T1 (en) | (R) - PILINDOL AND THE PHARMACEUTICALALLY ACCEPTABLE SALTS FOR USE IN MEDICINE | |
| MX371343B (en) | Liver x receptor (lxr) modulators. | |
| MX2016002930A (en) | Liver x receptor (lxr) modulators. | |
| UA97696U (en) | METHOD OF PREVENTING CHILD DEVELOPMENT IN CHILDREN | |
| PH12016502284A1 (en) | Cough medicine containing ambroxol hydrochloride | |
| FR3021219B1 (en) | OLIGO-PORPHYRANES, METHOD AND MEDICINAL PRODUCT | |
| NZ725067A (en) | Anti-tumor agent containing anti-tumor platinum complex, and anti-tumor effect enhancer | |
| PL2996675T3 (en) | Pharmaceutical formulation, process for preparing the pharmaceutical formulation and infusion solution and use thereof as medicinal product and/or as pharmaceutical | |
| PH12020500472A1 (en) | Autotaxin inhibitor compounds | |
| UA91737U (en) | Method for treating irritated bowel syndrome in children |